top of page
  • patricia5628

Nonprescription Intranasal Naloxone Approved by the FDA

Over the last 20 years it is estimated that over a million people have died from drug overdoses often associated with opioids. Post pandemic data indicate that opioid overdoses/deaths are increasing at a greater than previous rate and are now the leading cause of accidental death in the United States.

Today the FDA approved a nonprescription naloxone nasal spray packaged in two 4 mg doses by Emergent BioSolutions. The product should be available in pharmacies by late summer, 2023. While most States have a mechanism in place that allows pharmacists to provide treatment to at risk individuals without a personal prescription, approving an over the counter antidote will allow easier access and most definitely save lives.

8 views0 comments

Recent Posts

See All

Medications are intended to fix our medical problems but too often that isn't what happens. All medications come with side effects - some can be life threatening. 1. Adverse drug events (ADE) are unin

Naloxone is finally available in the US without a prescription but much more is needed to improve health outcomes among people with opioid use disorder (PWOUD). 1. Reclassification as an over-the-coun

A PGx test may be accomplished with a simple buccal swab. Each of us is unique - similarly how our body handles and responds to medication is unique. In many patients, PGx results can help to pinpoint

bottom of page